ISPOR - Closing The Evidence Gap For Orphan Drugs- Do German Regulatory Requirements Give Incentives For High Level Evidence Generation?

Full Text

Closing The Evidence Gap For Orphan Drugs- Do German Regulatory Requirements Give Incentives For High Level Evidence Generation?

Abstract

Authors

A Babac R Greiner D Bonduelle

Back to Volume 20, Issue 9

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now